House Report 113-023 - Oversight Plan for the Committee on Energy and Commerce 113th Congress (2013-2014)

FOOD AND DRUG ADMINISTRATION AND DRUG SAFETY

The Committee will review whether the Food and Drug Administration (FDA) is ensuring that regulated drugs are safe, effective, and available to American patients in an expeditious fashion. The Committee will also explore the interplay between these policies and drug innovation, both in the United States and abroad. Further, the Committee will examine FDA's enforcement of current drug safety laws and the issues involved in protecting the nation's supply chains against economically motivated and other forms of adulteration. The Committee will continue its investigation of FDA's handling of the 2012 fungal meningitis outbreak linked to contaminated, compounded drugs.

quoted from here